Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ACUVUE is a leading global brand of contact lenses and a primary division of Johnson & Johnson Vision Care. The company is recognized for pioneering the first disposable soft contact lens and continues to lead the market with innovations in material science and ocular health. Its extensive product portfolio includes daily disposable, reusable, and specialized lenses designed to correct myopia, hyperopia, astigmatism, and presbyopia. Notably, ACUVUE recently introduced the first drug-eluting contact lens, combining vision correction with antihistamine delivery for patients with allergic conjunctivitis. The brand emphasizes patient comfort and eye health through proprietary technologies like HydraLuxe and Blink-Stabilized Design. As a part of Johnson & Johnson, ACUVUE leverages significant R&D resources to advance the standard of care in optometry and ophthalmology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ACUVUE.